tradingkey.logo

TherapeuticsMD Inc

TXMD
2.290USD
+0.100+4.57%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
26.50MMarktkapitalisierung
87.50KGV TTM

TherapeuticsMD Inc

2.290
+0.100+4.57%

mehr Informationen über TherapeuticsMD Inc Unternehmen

TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

TherapeuticsMD Inc Informationen

BörsenkürzelTXMD
Name des UnternehmensTherapeuticsMD Inc
IPO-datumJan 31, 2001
CEOWalker (Marlan D)
Anzahl der mitarbeiter1
WertpapierartOrdinary Share
GeschäftsjahresendeJan 31
Addresse951 Yamato Road, Suite 220
StadtBOCA RATON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl33431
Telefon15619611900
Websitehttps://www.therapeuticsmd.com/
BörsenkürzelTXMD
IPO-datumJan 31, 2001
CEOWalker (Marlan D)

Führungskräfte von TherapeuticsMD Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
--
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Marlan D. Walker, J.D.
Mr. Marlan D. Walker, J.D.
Chief Executive Officer
Chief Executive Officer
73.64K
--
Mr. Cooper C. Collins
Mr. Cooper C. Collins
Independent Director
Independent Director
60.52K
--
Dr. Gail K. Naughton, Ph.D.
Dr. Gail K. Naughton, Ph.D.
Independent Director
Independent Director
8.50K
--
Mr. Joseph Ziegler
Mr. Joseph Ziegler
Principal Financial Officer, Principal Accounting Officer
Principal Financial Officer, Principal Accounting Officer
7.50K
--
Gov. Thomas G. (Tommy) Thompson, J.D.
Gov. Thomas G. (Tommy) Thompson, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Justin Roberts
Mr. Justin Roberts
Independent Director
Independent Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
448.00K
57.14%
Non-U.S
336.00K
42.86%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.43%
Tejara Capital Ltd.
3.03%
Adar1 Capital Management LLC
1.81%
Andere
75.94%
Aktionäre
Aktionäre
Anteil
Rubric Capital Management LP
10.30%
Clearline Capital LP
5.49%
The Vanguard Group, Inc.
3.43%
Tejara Capital Ltd.
3.03%
Adar1 Capital Management LLC
1.81%
Andere
75.94%
Aktionärstypen
Aktionäre
Anteil
Hedge Fund
18.44%
Investment Advisor
7.87%
Individual Investor
1.62%
Investment Advisor/Hedge Fund
1.39%
Research Firm
1.13%
Andere
69.55%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
82
3.33M
28.78%
-21.58K
2025Q3
82
3.26M
28.17%
-348.35K
2025Q2
88
5.28M
45.63%
+1.46M
2025Q1
93
3.58M
30.94%
-393.28K
2024Q4
95
3.73M
32.32%
-2.03M
2024Q3
99
3.59M
31.15%
-463.34K
2024Q2
121
3.62M
31.37%
-2.25M
2024Q1
209
3.66M
32.13%
-802.21K
2023Q4
230
4.54M
44.12%
-1.60M
2023Q3
274
4.44M
43.31%
-158.22K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Rubric Capital Management LP
1.19M
10.3%
--
--
Sep 30, 2025
Clearline Capital LP
635.22K
5.49%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
376.83K
3.26%
-2.17K
-0.57%
Sep 30, 2025
Tejara Capital Ltd.
344.20K
2.97%
-51.00
-0.01%
Sep 30, 2025
Adar1 Capital Management LLC
209.21K
1.81%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
129.59K
1.12%
-528.00
-0.41%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
116.13K
1%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
109.08K
0.94%
--
--
Sep 30, 2025
Walker (Marlan D)
73.64K
0.64%
--
--
Oct 20, 2025
Collins (Cooper C)
60.52K
0.52%
--
--
Oct 20, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
Datum
Ex-Dividendentag
Art
Verhältnis
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
May 06, 2022
Merger
50→1
KeyAI